BCAB [NASD]
BioAtla, Inc.
Index- P/E- EPS (ttm)-2.86 Insider Own5.40% Shs Outstand37.32M Perf Week2.38%
Market Cap95.15M Forward P/E- EPS next Y-2.68 Insider Trans7.52% Shs Float30.00M Perf Month23.36%
Income-101.00M PEG- EPS next Q-0.69 Inst Own72.20% Short Float13.41% Perf Quarter-35.96%
Sales0.30M P/S317.15 EPS this Y-147.10% Inst Trans-4.97% Short Ratio5.85 Perf Half Y-84.53%
Book/sh5.09 P/B0.59 EPS next Y3.60% ROA-41.20% Target Price31.00 Perf Year-93.37%
Cash/sh6.94 P/C0.43 EPS next 5Y- ROE-49.90% 52W Range2.01 - 47.86 Perf YTD-84.67%
Dividend- P/FCF- EPS past 5Y- ROI-45.40% 52W High-93.71% Beta-
Dividend %- Quick Ratio13.00 Sales past 5Y- Gross Margin- 52W Low49.75% ATR0.29
Employees56 Current Ratio13.00 Sales Q/Q- Oper. Margin- RSI (14)53.00 Volatility12.36% 10.94%
OptionableYes Debt/Eq0.00 EPS Q/Q-17.00% Profit Margin- Rel Volume0.56 Prev Close2.97
ShortableYes LT Debt/Eq0.00 EarningsMay 04 AMC Payout- Avg Volume687.38K Price3.01
Recom1.80 SMA207.40% SMA504.76% SMA200-78.57% Volume385,227 Change1.35%
May-05-22Downgrade Credit Suisse Outperform → Neutral $35 → $5
Mar-21-22Initiated H.C. Wainwright Buy $25
Oct-15-21Resumed BTIG Research Buy $68
Jun-28-21Initiated ROTH Capital Buy $75
May-05-21Resumed Credit Suisse Outperform $68
Apr-26-21Resumed Credit Suisse Outperform $68
Jan-11-21Initiated JP Morgan Overweight $45
Jan-11-21Initiated Jefferies Buy $51
Jan-11-21Initiated Credit Suisse Outperform $49
Jan-11-21Initiated BTIG Research Buy $47
Jun-04-22 08:12AM  
Jun-01-22 04:05PM  
May-04-22 04:01PM  
Apr-08-22 08:00AM  
Mar-01-22 06:00AM  
Feb-07-22 05:38PM  
Jan-10-22 04:05PM  
Dec-21-21 09:00AM  
Dec-11-21 06:34AM  
Nov-15-21 05:09PM  
Oct-04-21 10:56AM  
Sep-29-21 08:03AM  
Sep-12-21 08:49AM  
Aug-13-21 05:54PM  
Jun-14-21 02:03AM  
May-12-21 06:26PM  
Mar-16-21 01:59AM  
Dec-18-20 04:00PM  
Dec-16-20 05:34PM  
04:52PM  
Dec-15-20 07:59PM  
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHORT JAY M PHDChief Executive OfficerJun 22Buy2.9140,308117,2961,375,982Jun 23 04:59 PM
SHORT JAY M PHDChief Executive OfficerJun 21Buy2.7929,08281,0401,335,674Jun 23 04:59 PM
Vasquez ChristianSee RemarksJun 09Buy2.9710,00029,72074,525Jun 09 04:05 PM
Vasquez ChristianSee RemarksJun 08Buy3.0225,84878,18864,525Jun 09 04:05 PM
Vasquez ChristianSee RemarksJun 07Buy3.0414,15243,00738,677Jun 09 04:05 PM
Vasquez ChristianSee RemarksDec 02Sale21.762004,35125,259Dec 07 05:43 PM
Smith Scott AndrewPresidentDec 02Sale21.762,98464,918345,656Dec 07 05:41 PM
SHORT JAY M PHDChief Executive OfficerDec 02Sale21.764,811104,6661,320,811Dec 07 05:40 PM
Sievers EricChief Medical OfficerDec 02Sale21.7682017,83991,506Dec 07 05:41 PM
WALDRON RICHARD AChief Financial OfficerDec 02Sale21.761,43431,198134,469Dec 07 05:44 PM
WALDRON RICHARD AChief Financial OfficerDec 01Sale23.037,246166,910135,903Dec 07 05:44 PM
Sievers EricChief Medical OfficerDec 01Sale23.031733,98592,326Dec 07 05:41 PM
SHORT JAY M PHDChief Executive OfficerDec 01Sale23.0324,321560,2261,325,622Dec 07 05:40 PM
Smith Scott AndrewPresidentDec 01Sale23.0362814,466348,640Dec 07 05:41 PM
Vasquez ChristianSee RemarksDec 01Sale23.041,01123,28925,459Dec 07 05:43 PM
Vasquez ChristianSee RemarksNov 30Sale24.5176818,82226,470Dec 07 05:43 PM
Smith Scott AndrewPresidentNov 30Sale24.5147811,715349,268Dec 07 05:41 PM
SHORT JAY M PHDChief Executive OfficerNov 30Sale24.5118,490453,1541,349,943Dec 07 05:40 PM
Sievers EricChief Medical OfficerNov 30Sale24.511313,21192,499Dec 07 05:41 PM
WALDRON RICHARD AChief Financial OfficerNov 30Sale24.515,510135,040143,149Dec 07 05:44 PM
WALDRON RICHARD AChief Financial OfficerNov 29Sale23.894,599109,870148,659Dec 06 08:44 PM
Smith Scott AndrewPresidentNov 29Sale23.893999,532349,746Dec 06 08:42 PM
Vasquez ChristianSee RemarksNov 29Sale23.8964215,33727,238Dec 06 08:43 PM
Sievers EricChief Medical OfficerNov 29Sale23.891102,62892,630Dec 06 08:41 PM
SHORT JAY M PHDChief Executive OfficerNov 29Sale23.8915,435368,7421,368,433Dec 06 08:41 PM
Sievers EricChief Medical OfficerNov 24Sale24.871293,20892,740Nov 30 08:05 PM
SHORT JAY M PHDChief Executive OfficerNov 24Sale24.8717,022423,3141,383,868Nov 30 08:04 PM
Smith Scott AndrewPresidentNov 24Sale24.8746611,589350,145Nov 30 08:06 PM
Vasquez ChristianSee RemarksNov 24Sale24.8775018,65127,880Nov 30 08:07 PM
WALDRON RICHARD AChief Financial OfficerNov 24Sale24.873,93797,909153,258Nov 30 08:07 PM
WALDRON RICHARD AChief Financial OfficerNov 23Sale24.925,770143,801157,195Nov 30 08:07 PM
Vasquez ChristianSee RemarksNov 23Sale24.921,10027,41528,630Nov 30 08:07 PM
Smith Scott AndrewPresidentNov 23Sale24.9268417,047350,611Nov 30 08:06 PM
SHORT JAY M PHDChief Executive OfficerNov 23Sale24.9224,943621,6341,400,890Nov 30 08:04 PM
Sievers EricChief Medical OfficerNov 23Sale24.921874,66092,869Nov 30 08:05 PM
Sievers EricChief Medical OfficerNov 22Sale26.231183,09693,056Nov 30 08:05 PM
SHORT JAY M PHDChief Executive OfficerNov 22Sale26.2315,675411,2341,425,833Nov 30 08:04 PM
Smith Scott AndrewPresidentNov 22Sale26.2343011,281351,295Nov 30 08:06 PM
Vasquez ChristianSee RemarksNov 22Sale26.2369118,12829,730Nov 30 08:07 PM
WALDRON RICHARD AChief Financial OfficerNov 22Sale26.233,62695,128162,965Nov 30 08:07 PM
STEINMAN LAWRENCEDirectorNov 02Sale30.0045013,50018,459Nov 03 05:09 PM
Smith Scott AndrewPresidentOct 01Sale30.182,99490,351351,725Oct 07 06:09 PM
Sievers EricChief Medical OfficerOct 01Sale30.3959217,99393,174Oct 07 06:08 PM
STEINMAN LAWRENCEDirectorSep 15Sale36.8245016,56918,909Sep 17 02:05 PM
Sievers EricChief Medical OfficerAug 26Sale39.596,883272,49693,766Aug 30 09:42 PM
Smith Scott AndrewPresidentAug 26Sale40.1633,2441,334,927354,719Aug 30 09:43 PM
SHORT JAY M PHDChief Executive OfficerAug 24Option Exercise18.007,747139,446798,080Aug 26 05:41 PM
Levy GuyDirectorAug 24Sale39.65546,70921,677,012217,358Aug 26 08:05 PM
SHORT JAY M PHDChief Executive OfficerAug 24Sale41.604,533188,573793,547Aug 26 05:41 PM
STEINMAN LAWRENCEDirectorAug 16Sale40.6045018,27019,359Aug 18 05:48 PM
STEINMAN LAWRENCEDirectorJul 15Sale38.2945017,23019,809Jul 19 09:25 PM